Notes And Other Explanatory Information [Abstract]
| Concept |
2022-01-01 to 2022-12-31 |
|---|---|
| Notes and other explanatory information [abstract] | |
| Disclosure of accounting judgements and estimates [text block] |
1.3.
|
| Disclosure of accrued expenses and other liabilities [text block] |
7.6.
|
| Disclosure of allowance for credit losses [text block] |
Le solde clients se décompose ainsi par tranche (en K€) :
|
| Disclosure of authorisation of financial statements [text block] |
|
| Disclosure of business combinations [text block] |
2.2.
|
| Disclosure of changes in accounting policies, accounting estimates and errors [text block] |
1.1.2.
|
| Disclosure of collateral [text block] |
(2)
|
| Disclosure of claims and benefits paid [text block] |
NOTE 12. -
|
| Disclosure of commitments [text block] |
7.9.
|
| Disclosure of commitments and contingent liabilities [text block] |
6.7.
|
| Disclosure of credit risk [text block] |
Sur la base d’analyse de risque de contrepartie régulièrement actualisée, les créances sur les principaux débiteurs, représentés par les différents leasers actifs auprès des pharmaciens, ne font pas l’objet de dépréciation significative (retards de paiement très majoritairement inférieurs à 2 mois). La part des facturations financées par les leasers représente 32,3 % du chiffre d’affaires dont l'essentiel est réalisé par les leasers en relation régulière avec HEALTHLEASE et NANCEO.
|
| Disclosure of depreciation and amortisation expense [text block] |
3.3.
|
| Disclosure of employee benefits [text block] |
9.2.
|
| Disclosure of entity's operating segments [text block] |
7.2.
|
| Disclosure of events after reporting period [text block] |
NOTE 16. -
|
| Disclosure of fee and commission income (expense) [text block] |
7.8.
|
| Disclosure of finance income [text block] |
6.5.
|
| Disclosure of financial risk management [text block] |
6.6.
|
| Disclosure of general and administrative expense [text block] |
NOTE 8. -
|
| Disclosure of goodwill [text block] |
3.1.
|
| Disclosure of income tax [text block] |
NOTE 10. -
|
| Disclosure of information about employees [text block] |
9.1.
|
| Disclosure of information about key management personnel [text block] |
9.4.
|
| Disclosure of intangible assets [text block] |
NOTE 3. -
|
| Disclosure of interest expense [text block] |
(2)
|
| Disclosure of interest income [text block] |
(1)
|
| Disclosure of information about interim financial reporting [text block] |
18.2.1.
|
| Disclosure of investments accounted for using equity method [text block] |
2.1.2.
|
| Disclosure of investments other than investments accounted for using equity method [text block] |
2.1.3.
|
| Disclosure of liquidity risk [text block] |
6.6.1.
|
| Disclosure of market risk [text block] |
6.6.2.
|
| Disclosure of other assets [text block] |
3.4.
|
| Disclosure of other non-current assets [text block] |
6.1.
|
| Disclosure of profit (loss) from operating activities [text block] |
1.2.1.
|
| Disclosure of research and development expense [text block] |
3.2.
|
| Disclosure of share capital, reserves and other equity interest [text block] |
11.1.
|
| Disclosure of share-based payment arrangements [text block] |
9.3.
|
| Disclosure of treasury shares [text block] |
11.2.
|